Literature DB >> 31007084

Microparticles and cardiovascular diseases.

Christos Voukalis1, Eduard Shantsila1, Gregory Y H Lip2,3.   

Abstract

Microparticles are a distinctive group of small vesicles, without nucleus, which are involved as significant modulators in several physiological and pathophysiological mechanisms. Plasma microparticles from various cellular lines have been subject of research. Data suggest that they are key players in development and manifestation of cardiovascular diseases and their presence, in high levels, is associated with chronic inflammation, endothelial damage and thrombosis. The strong correlation of microparticle levels with several outcomes in cardiovascular diseases has led to their utilization as biomarkers. Despite the limited clinical application at present, their significance emerges, mainly because their detection and enumeration methods are improving. This review article summarizes the evidence derived from research, related with the genesis and the function of microparticles in the presence of various cardiovascular risk factors and conditions. The current data provide a substrate for several theories of how microparticles influence various cellular mechanisms by transferring biological information.

Entities:  

Keywords:  Microparticles; atherosclerosis; cardiovascular; heart failure ; inflammation; thrombosis

Mesh:

Substances:

Year:  2019        PMID: 31007084      PMCID: PMC7877885          DOI: 10.1080/07853890.2019.1609076

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  295 in total

1.  Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction.

Authors:  C M Boulanger; A Scoazec; T Ebrahimian; P Henry; E Mathieu; A Tedgui; Z Mallat
Journal:  Circulation       Date:  2001-11-27       Impact factor: 29.690

Review 2.  New horizons in the analysis of circulating cell-derived microparticles.

Authors:  Lawrence L Horstman; Wenche Jy; Joaquin J Jimenez; Carlos Bidot; Yeon S Ahn
Journal:  Keio J Med       Date:  2004-12

3.  Phagocytosis of microparticles by alveolar macrophages during acute lung injury requires MerTK.

Authors:  Michael P Mohning; Stacey M Thomas; Lea Barthel; Kara J Mould; Alexandria L McCubbrey; S Courtney Frasch; Donna L Bratton; Peter M Henson; William J Janssen
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-09-21       Impact factor: 5.464

4.  Identification of a factor that links apoptotic cells to phagocytes.

Authors:  Rikinari Hanayama; Masato Tanaka; Keiko Miwa; Azusa Shinohara; Akihiro Iwamatsu; Shigekazu Nagata
Journal:  Nature       Date:  2002-05-09       Impact factor: 49.962

5.  Significance of platelet-derived microparticles and activated platelets in diabetic nephropathy.

Authors:  S Omoto; S Nomura; A Shouzu; T Hayakawa; H Shimizu; Y Miyake; T Yonemoto; M Nishikawa; S Fukuhara; M Inada
Journal:  Nephron       Date:  1999       Impact factor: 2.847

6.  Cholesterol enrichment of human monocyte/macrophages induces surface exposure of phosphatidylserine and the release of biologically-active tissue factor-positive microvesicles.

Authors:  Ming-Lin Liu; Michael P Reilly; Peter Casasanto; Steven E McKenzie; Kevin Jon Williams
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-12-07       Impact factor: 8.311

Review 7.  The role of microparticles in the pathogenesis of rheumatic diseases.

Authors:  Christian Beyer; David S Pisetsky
Journal:  Nat Rev Rheumatol       Date:  2009-12-01       Impact factor: 20.543

8.  High glucose condition increases NADPH oxidase activity in endothelial microparticles that promote vascular inflammation.

Authors:  Felix Jansen; Xiaoyan Yang; Bernardo S Franklin; Marion Hoelscher; Theresa Schmitz; Jörg Bedorf; Georg Nickenig; Nikos Werner
Journal:  Cardiovasc Res       Date:  2013-01-22       Impact factor: 10.787

9.  Tissue factor-containing microparticles released from mesangial cells in response to high glucose and AGE induce tube formation in microvascular cells.

Authors:  Camille Ettelaie; Shenghui Su; Chao Li; Mary E W Collier
Journal:  Microvasc Res       Date:  2008-08-05       Impact factor: 3.514

10.  The origin of circulating CD36 in type 2 diabetes.

Authors:  M J Alkhatatbeh; A K Enjeti; S Acharya; R F Thorne; L F Lincz
Journal:  Nutr Diabetes       Date:  2013-02-04       Impact factor: 5.097

View more
  11 in total

1.  An injectable conductive hydrogel restores electrical transmission at myocardial infarct site to preserve cardiac function and enhance repair.

Authors:  Linghong Zhang; Tao Li; Yan Yu; Kun Shi; Zhongwu Bei; Yongjun Qian; Zhiyong Qian
Journal:  Bioact Mater       Date:  2022-06-13

Review 2.  Regulation of Nrf2 signaling pathway in heart failure: Role of extracellular vesicles and non-coding RNAs.

Authors:  Changhai Tian; Lie Gao; Irving H Zucker
Journal:  Free Radic Biol Med       Date:  2021-03-17       Impact factor: 7.376

3.  The Clinical Significance of Circulating Microparticles Concerning Thrombosis in BCR/ABL1-negative Myeloproliferative Neoplasms.

Authors:  Mohamed Hussam Aswad; Jarmila Kissova; Petra Ovesna; Lucie Rihova; Miroslav Penka
Journal:  In Vivo       Date:  2021 Nov-Dec       Impact factor: 2.155

Review 4.  Exposure to Perfluoroalkyl Chemicals and Cardiovascular Disease: Experimental and Epidemiological Evidence.

Authors:  Alessandra Meneguzzi; Cristiano Fava; Marco Castelli; Pietro Minuz
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-09       Impact factor: 5.555

5.  Analysis of Circulating Microvesicles Levels and Effects of Associated Factors in Elderly Patients With Obstructive Sleep Apnea.

Authors:  Jin Tan; Huifang Xing; Sha Sha; Jinwen Li; Yuyang Miao; Qiang Zhang
Journal:  Front Aging Neurosci       Date:  2021-02-24       Impact factor: 5.750

Review 6.  Extracellular Vesicles in Atrial Fibrillation-State of the Art.

Authors:  Grzegorz Procyk; Dominik Bilicki; Paweł Balsam; Piotr Lodziński; Marcin Grabowski; Aleksandra Gąsecka
Journal:  Int J Mol Sci       Date:  2022-07-08       Impact factor: 6.208

Review 7.  Extracellular Vesicles, Inflammation, and Cardiovascular Disease.

Authors:  Akbarshakh Akhmerov; Tanyalak Parimon
Journal:  Cells       Date:  2022-07-18       Impact factor: 7.666

8.  Impact of Epicatechin on the Procoagulant Activities of Microparticles.

Authors:  Thomas Sinegre; Dragan Milenkovic; Céline Bourgne; Dorian Teissandier; Yosra Nasri; Louis-Thomas Dannus; Christine Morand; Aurélien Lebreton
Journal:  Nutrients       Date:  2020-09-25       Impact factor: 5.717

9.  Procoagulant microparticles are associated with arterial disease in patients with systemic lupus erythematosus.

Authors:  Miguel Angel Plasín-Rodríguez; Patricia Patricio; Joan Monteagudo; Angeles García-Criado; Ricard Cervera; Joan Carles Reverter; Gerard Espinosa; Dolors Tàssies
Journal:  J Thromb Thrombolysis       Date:  2020-10-03       Impact factor: 2.300

10.  Circulating endothelial microparticles: a promising biomarker of acute kidney injury after cardiac surgery with cardiopulmonary bypass.

Authors:  Jian Ma; Hao-Xiang Yuan; Ya-Ting Chen; Da-Sheng Ning; Xiao-Jun Liu; Yue-Ming Peng; Chao Chen; Yuan-Kai Song; Yu-Peng Jian; Yan Li; Zui Liu; Zhi-Jun Ou; Jing-Song Ou
Journal:  Ann Transl Med       Date:  2021-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.